Long-term survival of two patients with recurrent high-risk neuroblastoma

被引：2
|
作者：
Sato, Tomonobu [1 ]
Hara, Kazuya [2 ]
Ohba, Go [3 ]
Yamamoto, Hiroshi [3 ]
Iguchi, Akihiro [2 ]
机构：
[1] Kitami Red Cross Hosp, Dept Pediat, North 6 East 2, Kitami, Hokkaido 0908666, Japan
[2] Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido, Japan
[3] Bokoi Tenshi Hosp, Dept Pediat Surg, Sapporo, Hokkaido, Japan
来源：
PEDIATRICS INTERNATIONAL | 2021年 / 63卷 / 07期
关键词：
aggressive surgical intervention; high-risk neuroblastoma (HR-NB); recurrent neuroblastoma; refractory neuroblastoma;
D O I：
10.1111/ped.14489
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
[No abstract available]
引用
收藏
页码：849 / 851
页数：3
相关论文
共 50 条
  • [41] FACTORS RELATED TO GROWTH RETARDATION IN LONG-TERM HIGH-RISK NEUROBLASTOMA SURVIVORS TREATED WITH HIGH-DOSE CHEMOTHERAPY
    Haghiri, Sandrine
    Karamouza, Eleni
    Fayech, Chiraz
    Thebault, Eric
    Allard, Julie
    Thomas-Teinturier, Cecile
    Dufour, Christelle
    Bolle, Stephanie
    Haddy, Nadia
    De Vathaire, Florent
    Valteau-Couanet, Dominique
    Le Teuff, Gwenael
    Fresneau, Brice
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S487 - S488
  • [42] Improved Long-Term Survival after Myeloablative Chemotherapy with Autologous Stem Cell Transplantation in High-Risk Neuroblastoma Patients. Results of the NB97 Trial
    Simon, T.
    Hero, B.
    Ruth, V.
    Angelika, E.
    Frank, B.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S39 - S39
  • [43] Long-term survival in high-risk older adults following emergency general surgery admission
    Guttman, Matthew P.
    Tillmann, Bourke W.
    Nathens, Avery B.
    Saskin, Refik
    Bronskill, Susan E.
    Huang, Anjie
    Haas, Barbara
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2021, 91 (04): : 634 - 640
  • [44] Long-term survival after multivessel surgical or percutaneous revascularization: analysis of high-risk groups
    Brener, S
    Lytle, BW
    Casserly, I
    Schneider, JP
    Lauer, MS
    Ellis, SG
    Topol, EJ
    EUROPEAN HEART JOURNAL, 2003, 24 : 80 - 80
  • [45] Long-Term Maintenance with Lenalidomide Improves Progression Free Survival In Myeloma Patients with High-Risk Cytogenetics: An IFM Study
    Avet-Loiseau, Herve
    Caillot, Denis
    Marit, Gerald
    Lauwers-Cances, Valerie
    Roussel, Murielle
    Facon, Thierry
    Hulin, Cyrille
    Lamy, Thierry
    Pegourie, Brigitte
    Maisonneuve, Herve
    Garderet, Laurent
    Moreau, Philippe
    Stoppa, Anne-Marie
    Dib, Mamoun
    Jaubert, Jerome
    Casassus, Philippe
    Mathiot, Claire
    Harousseau, Jean-Luc
    Moreau, Philippe
    Attal, Michel
    BLOOD, 2010, 116 (21) : 810 - 810
  • [46] Toxicity and survival outcomes in high-risk neuroblastoma in childhood
    Selles, E. Gomis
    Cabrera Roldan, P.
    Delgado-Leon, B. D.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1178 - S1178
  • [47] Long-term follow-up of children with high-risk neuroblastoma: The ENSG5 trial experience
    Moreno, Lucas
    Vaidya, Sucheta J.
    Pinkerton, C. Ross
    Lewis, Ian J.
    Imeson, John
    Machin, David
    Pearson, Andrew D. J.
    PEDIATRIC BLOOD & CANCER, 2013, 60 (07) : 1135 - 1140
  • [48] Musculoskeletal outcomes and the effect of radiation to the vertebral bodies on growth trajectories for long-term survivors of high-risk neuroblastoma
    Ferris, Matthew J.
    Tian, Sibo
    Switchenko, Jeffrey M.
    Madden, Nicholas A.
    Eaton, Bree R.
    Esiashvili, Natia
    JOURNAL OF RADIATION ONCOLOGY, 2018, 7 (02) : 187 - 193
  • [49] Musculoskeletal Outcomes and the Effect of Radiation to the Vertebral Bodies on Growth Trajectories for Long-Term Survivors of High-Risk Neuroblastoma
    Ferris, M. J.
    Tian, S.
    Switchenko, J.
    Eaton, B. R.
    Esiashvili, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E567 - E567
  • [50] Overall survival and event free survival in patients with high-risk neuroblastoma after targeted therapy
    Mazankova, D.
    Mazanek, P.
    Maskova, V.
    Tinka, P.
    Kyr, M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (06) : 1546 - 1546
12345